Western firms show growing interest in traditional Chinese medicine

03/27/2013 | China Daily (Beijing)

Pharmaceutical firms from Europe, Japan, South Korea and the United States are investing in the development of medications and treatments derived from traditional Chinese medicine. GlaxoSmithKline, for example, recently announced a traditional Chinese medicine program based in Shanghai that will target both a Chinese and global market. "Our priority is to transform TCM from an experience-based practice to evidence-based medicines through innovation and differentiation," said Jingwu Zang, head of R&D for GlaxoSmithKline in China.

View Full Article in:

China Daily (Beijing)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Associate, Health Economics - Heart Valve Therapy
Edwards Lifesciences
Irvine, CA
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD